Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ileana Piña MD, MPH, FAHA, FACC
Ileana L. Piña MD, MPH, FAHA, FACC Advisory Board
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
See All Experts
story of the week
Published in Cardiology

Journal Scan / Research · December 04, 2024

Effects of Tirzepatide on Circulatory Overload and End-Organ Damage in Patients With HFpEF and Obesity

Nature Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Giselle Suero-Abreu MD, PhD, MSc

Nature Medicine
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
Nat. Med. 2024 Nov 17;[EPub Ahead of Print], BA Borlaug, MR Zile, CM Kramer, SJ Baum, K Hurt, SE Litwin, M Murakami, Y Ou, N Upadhyay, M Packer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated